Berberine inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells

被引:34
作者
Moon, Phil-Dong [1 ]
Choi, In-Hwa [2 ]
Kim, Hyung-Min [1 ]
机构
[1] Kyung Hee Univ, Inst Oriental Med, Dept Pharmacol, Coll Oriental Med, Seoul 130701, South Korea
[2] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Oriental Dermatol, Coll Oriental Med, Seoul 134727, South Korea
基金
新加坡国家研究基金会;
关键词
Thymic stromal lymphopoietin; Berberine; Nuclear factor-kappa B; Caspase-1; NF-KAPPA-B; IN-VITRO; DERMATITIS; EXPRESSION; SKIN; INFLAMMATION; RECEPTOR; GROWTH; TSLP; ACTIVATION;
D O I
10.1016/j.intimp.2011.08.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Thymic stromal lymphopoietin (TSLP) plays a pivotal role in allergic diseases such as atopic dermatitis, asthma, and chronic obstructive pulmonary disease. However, it has not been clarified the effect of berberine (BER) on the production of TSLP yet. Thus, we investigated how BER inhibits the production of TSLP in the human mast cell line (HMC-1) cells. We used enzyme-linked immunosorbent assay, reverse transcription-polymerase chain reaction, luciferase assay, and Western blot analysis to investigate the effects of BER. BER inhibited the production and mRNA expression of TSLP in HMC-1 cells. BER also inhibited the nuclear factor-kappa B luciferase activity induced by phorbol myristate acetate plus A23187. BER inhibited the activation of caspase-1 in HMC-1 cells. Furthermore, BER inhibited the production of TSLP in primary mast cells. These results provide evidence that BER can help to treat inflammatory and atopic diseases through the inhibition of TSLP. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1954 / 1959
页数:6
相关论文
共 35 条
[1]
Targeting caspase-1 by inhalation-therapy:: effects of Ac-YVAD-CHO on IL-1β, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia [J].
Boost, Kim A. ;
Hoegl, Sandra ;
Hofstetter, Christian ;
Flondor, Michael ;
Stegewerth, Klaus ;
Platacis, Ilka ;
Pfeilschifter, Josef ;
Muhl, Heiko ;
Zwissler, Bernhard .
INTENSIVE CARE MEDICINE, 2007, 33 (05) :863-871
[2]
Atopic Dermatitis-Like Disease and Associated Lethal Myeloproliferative Disorder Arise from Loss of Notch Signaling in the Murine Skin [J].
Dumortier, Alexis ;
Durham, Andre-Dante ;
Di Piazza, Matteo ;
Vauclair, Sophie ;
Koch, Ute ;
Ferrand, Gisele ;
Ferrero, Isabel ;
Demehri, Shadmehr ;
Song, Lynda Li ;
Farr, Andrew G. ;
Leonard, Warren J. ;
Kopan, Raphael ;
Miele, Lucio ;
Hohl, Daniel ;
Finke, Daniela ;
Radtke, Freddy .
PLOS ONE, 2010, 5 (02)
[3]
FRIEND SL, 1994, EXP HEMATOL, V22, P321
[4]
Inhibition of human caspases by peptide-based and macromolecular inhibitors [J].
Garcia-Calvo, M ;
Peterson, EP ;
Leiting, B ;
Ruel, R ;
Nicholson, DW ;
Thornberry, NA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :32608-32613
[5]
MAST-CELLS AS A SOURCE OF MULTIFUNCTIONAL CYTOKINES [J].
GORDON, JR ;
BURD, PR ;
GALLI, SJ .
IMMUNOLOGY TODAY, 1990, 11 (12) :458-464
[6]
Huh J., 1999, DONGUIBOGAM
[7]
ICEBERG:: A novel inhibitor of interleukin-1β generation [J].
Humke, EW ;
Shriver, SK ;
Starovasnik, MA ;
Fairbrother, WJ ;
Dixit, VM .
CELL, 2000, 103 (01) :99-111
[8]
Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway [J].
Jiang, Qin ;
Liu, Peiqing ;
Wu, Xiaoqian ;
Liu, Weihua ;
Shen, Xiaoyan ;
Lan, Tian ;
Xu, Suowen ;
Peng, Jing ;
Xie, Xi ;
Huang, Heqing .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 331 (01) :34-40
[9]
Inhibition of atopic dermatitis-like skin lesions by topical application of a novel ceramide derivative, K6PC-9p, in NC/Nga mice [J].
Kang, Jong Soon ;
Yoon, Won Kee ;
Youm, Jong-Kyung ;
Jeong, Se Kyoo ;
Park, Byeong Deog ;
Han, Mi Hwa ;
Lee, Hyunju ;
Moon, Eun-Yi ;
Han, Sang-Bae ;
Lee, Chang Woo ;
Lee, Kiho ;
Park, Song-Kyu ;
Yang, Kyu-Hwan ;
Kim, Hwan Mook .
EXPERIMENTAL DERMATOLOGY, 2008, 17 (11) :958-964
[10]
The anti-inflammatory potential of berberine in vitro and in vivo [J].
Kuo, CL ;
Chi, CW ;
Liu, TY .
CANCER LETTERS, 2004, 203 (02) :127-137